Stay updated on Orlistat Adjuvant in Obesity: Clinical Trial

Sign up to get notified when there's something new on the Orlistat Adjuvant in Obesity: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Orlistat Adjuvant in Obesity: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the evaluation of efficacy of orlistat 60 mg as adjuvant treatment of obesity in adults.
    Difference
    0.2%
    Check dated 2024-06-06T14:23:41.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study. The new criteria specify inclusion and exclusion factors such as age, BMI, pregnancy status, and certain medical conditions.
    Difference
    16%
    Check dated 2024-05-22T20:28:05.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:26:15.000Z thumbnail image

Stay in the know with updates to Orlistat Adjuvant in Obesity: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Orlistat Adjuvant in Obesity: Clinical Trial page.